[HTML][HTML] Marfan syndrome revisited: From genetics to clinical practice

SG Coelho, AG Almeida - Revista Portuguesa de Cardiologia (English …, 2020 - Elsevier
Marfan syndrome is an autosomal dominant connective tissue disease with an estimated
incidence of 1 in 5000 individuals. In 90% of cases it is caused by mutations in the gene for …

Marfan syndrome. Part 1: pathophysiology and diagnosis

V Cañadas, I Vilacosta, I Bruna, V Fuster - Nature Reviews Cardiology, 2010 - nature.com
Marfan syndrome is a connective-tissue disease inherited in an autosomal dominant
manner and caused mainly by mutations in the gene FBN1. This gene encodes fibrillin-1, a …

Therapeutic management of patients with Marfan syndrome: focus on cardiovascular involvement

CA NIENABER, Y VON KODOLITSCH - Cardiology in review, 1999 - journals.lww.com
Marfan syndrome is an autosomal dominant disorder of the connective tissues, with mutation
on the fibrillin-1 gene encoding for fibrillin, a major component of the extracellular …

[HTML][HTML] Marfan syndrome: An eyesight of syndrome

A Kumar, S Agarwal - Meta Gene, 2014 - Elsevier
Marfan syndrome (MFS), a relatively common autosomal dominant hereditary disorder of
connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular …

[HTML][HTML] Cardiovascular management of adults with Marfan syndrome

Y Isekame, S Gati, JA Aragon-Martin… - European Cardiology …, 2016 - ncbi.nlm.nih.gov
Marfan syndrome (MFS) is a disease in which connective tissue becomes weak secondary
to fibrillin-1 mutations, resulting in aortic dilatation, aneurysm formation, aortic dissection …

[HTML][HTML] Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?

P Matt, J Habashi, T Carrel, DE Cameron… - The Journal of thoracic …, 2008 - Elsevier
OBJECTIVE: Marfan syndrome is a systemic connective tissue disorder caused by mutations
in the fibrillin-1 gene. It was originally believed that Marfan syndrome results exclusively …

The translational science of Marfan syndrome

G Jondeau, JB Michel, C Boileau - Heart, 2011 - heart.bmj.com
Marfan syndrome has changed over the last few years: new diagnostic criteria have been
proposed, new clinical entities recognised and life expectancy increased. The role of fibrillin …

Marfan syndrome: an update of genetics, medical and surgical management

Y Von Kodolitsch, PN Robinson - Heart, 2007 - heart.bmj.com
Marfan syndrome is a heritable disorder of the connective tissue with an estimated
prevalence of 1 in 5000 individuals and no predilection for either sex. The syndrome is …

Marfan syndrome: A therapeutic challenge for long-term care

AH Wagner, M Zaradzki, R Arif, A Remes… - Biochemical …, 2019 - Elsevier
Marfan syndrome (MFS) is an autosomal dominant genetic disorder caused by mutations in
the fibrillin-1 gene. Acute aortic dissection is the leading cause of death in patients suffering …

Medical management of Marfan syndrome

MG Keane, RE Pyeritz - Circulation, 2008 - Am Heart Assoc
who has some but not enough features for a clinical diagnosis and no or an uncertain family
history, molecular analysis is of minimal help. The real benefit of DNA analysis arises when …